X

NOD.SCID mice Related Publications

Back to Previous Page
Expand All Tabs

Abbruzzese, C., Catalogna, G., Gallo, E., di Martino, S., Mileo, A. M., Carosi, M., . . . Paggi, M. G. (2017). The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme. Oncotarget, 8(67), 110743-110755. doi:10.18632/oncotarget.22500 [doi] Read Publication

Adam, C., Baeurle, A., Brodsky, J. L., Wipf, P., Schrama, D., Becker, J. C., & Houben, R. (2014). The HSP70 modulator MAL3-101 inhibits merkel cell carcinoma. PloS One, 9(4), e92041. doi:10.1371/journal.pone.0092041 [doi] Read Publication

Airoldi, I., Di Carlo, E., Cocco, C., Caci, E., Cilli, M., Sorrentino, C., . . . Pistoia, V. (2009). IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. PloS One, 4(7), e6119. doi:10.1371/journal.pone.0006119 [doi] Read Publication

Airoldi, I., Tupone, M. G., Esposito, S., Russo, M. V., Barbarito, G., Cipollone, G., & Di Carlo, E. (2015). Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget, 6(6), 3694-3708. doi:2797 [pii] Read Publication

Baertsch, M. A., Leber, M. F., Bossow, S., Singh, M., Engeland, C. E., Albert, J., . . . Ungerechts, G. (2014). MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus. Cancer Gene Therapy, 21(9), 373-380. doi:10.1038/cgt.2014.40 [doi] Read Publication

Balvers, R. K., Belcaid, Z., van den Hengel, S. K., Kloezeman, J., de Vrij, J., Wakimoto, H., . . . Lamfers, M. L. (2014). Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma. Viruses, 6(8), 3080-3096. doi:10.3390/v6083080 [doi] Read Publication

Boer, J. C., Domanska, U. M., Timmer-Bosscha, H., Boer, I. G., de Haas, C. J., Joseph, J. V., . . . Walenkamp, A. M. (2013). Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis inhibitory protein of S. aureus. British Journal of Cancer, 108(3), 587-596. doi:10.1038/bjc.2012.603 [doi] Read Publication

Boi, M., Gaudio, E., Bonetti, P., Kwee, I., Bernasconi, E., Tarantelli, C., . . . Bertoni, F. (2015). The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(7), 1628-1638. doi:10.1158/1078-0432.CCR-14-1561 [doi] Read Publication

Boi, M., Gaudio, E., Bonetti, P., Kwee, I., Bernasconi, E., Tarantelli, C., . . . Bertoni, F. (2015). The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(7), 1628-1638. doi:10.1158/1078-0432.CCR-14-1561 [doi] Read Publication

Bruckheimer, E. M., Fazenbaker, C. A., Gallagher, S., Mulgrew, K., Fuhrmann, S., Coffman, K. T., . . . Coats, S. (2009). Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors. Neoplasia (New York, N.Y.), 11(6), 509-17, 2 p following 517. Read Publication

Buoncervello, M., Romagnoli, G., Buccarelli, M., Fragale, A., Toschi, E., Parlato, S., . . . Gabriele, L. (2016). IFN-alpha potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer. Oncotarget, 7(18), 26361-26373. doi:10.18632/oncotarget.8379 [doi] Read Publication

Burns, T. F., Dobromilskaya, I., Murphy, S. C., Gajula, R. P., Thiyagarajan, S., Chatley, S. N., . . . Rudin, C. M. (2013). Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer. Molecular Cancer Research : MCR, 11(4), 329-338. doi:10.1158/1541-7786.MCR-12-0456 [doi] Read Publication

Chao, M. W., Chu, P. C., Chuang, H. C., Shen, F. H., Chou, C. C., Hsu, E. C., . . . Chen, C. S. (2016). Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. Oncotarget, 7(2), 1796-1807. doi:10.18632/oncotarget.6427 [doi] Read Publication

Cheng, K. W., Mattheolabakis, G., Wong, C. C., Ouyang, N., Huang, L., Constantinides, P. P., & Rigas, B. (2012). Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer. International Journal of Oncology, 41(4), 1199-1203. doi:10.3892/ijo.2012.1577 [doi] Read Publication

Cocco, C., Giuliani, N., Di Carlo, E., Ognio, E., Storti, P., Abeltino, M., . . . Airoldi, I. (2010). Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 16(16), 4188-4197. doi:10.1158/1078-0432.CCR-10-0173 [doi] Read Publication

Cosco, D., Cilurzo, F., Maiuolo, J., Federico, C., Di Martino, M. T., Cristiano, M. C., . . . Paolino, D. (2015). Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma. Scientific Reports, 5, 17579. doi:10.1038/srep17579 [doi] Read Publication

Cosco, D., Paolino, D., De Angelis, F., Cilurzo, F., Celia, C., Di Marzio, L., . . . Fresta, M. (2015). Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 89, 30-39. doi:10.1016/j.ejpb.2014.11.012 [doi] Read Publication

Dahlmann, M., & Stein, U. (2015). RNA interference for antimetastatic therapy. Methods in Molecular Biology (Clifton, N.J.), 1317, 153-165. doi:10.1007/978-1-4939-2727-2_10 [doi] Read Publication

D'Alesio, C., Punzi, S., Cicalese, A., Fornasari, L., Furia, L., Riva, L., . . . Lanfrancone, L. (2016). RNAi screens identify CHD4 as an essential gene in breast cancer growth. Oncotarget, 7(49), 80901-80915. doi:10.18632/oncotarget.12646 [doi] Read Publication

Damelin, M., Bankovich, A., Park, A., Aguilar, J., Anderson, W., Santaguida, M., . . . Dylla, S. J. (2015). Anti-EFNA4 calicheamicin conjugates effectively target triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regressions. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(18), 4165-4173. doi:10.1158/1078-0432.CCR-15-0695 [doi] Read Publication

Davidi, S., Fremder, E., Kan, T., Raviv, Z., Timaner, M., Karin, N., . . . Shaked, Y. (2017). The antiangiogenic role of the pro-inflammatory cytokine interleukin-31. Oncotarget, 8(10), 16430-16444. doi:10.18632/oncotarget.14857 [doi] Read Publication

Dey, J., Deckwerth, T. L., Kerwin, W. S., Casalini, J. R., Merrell, A. J., Grenley, M. O., . . . Klinghoffer, R. A. (2017). Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk diffuse large B-cell lymphoma to BCL2 inhibition. Scientific Reports, 7(1), 18007-017-18368-w. doi:10.1038/s41598-017-18368-w [doi] Read Publication

Di Martino, M. T., Gulla, A., Gallo Cantafio, M. E., Altomare, E., Amodio, N., Leone, E., . . . Tassone, P. (2014). In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. PloS One, 9(2), e89659. doi:10.1371/journal.pone.0089659 [doi] Read Publication

Di Meo, C., Cilurzo, F., Licciardi, M., Scialabba, C., Sabia, R., Paolino, D., . . . Matricardi, P. (2015). Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy. Pharmaceutical Research, 32(5), 1557-1569. doi:10.1007/s11095-014-1557-2 [doi] Read Publication

Dold, C., Rodriguez Urbiola, C., Wollmann, G., Egerer, L., Muik, A., Bellmann, L., . . . von Laer, D. (2016). Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy. Molecular Therapy Oncolytics, 3, 16021. doi:10.1038/mto.2016.21 [doi] Read Publication

Fareh, M., Turchi, L., Virolle, V., Debruyne, D., Almairac, F., de-la-Forest Divonne, S., . . . Virolle, T. (2012). The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death and Differentiation, 19(2), 232-244. doi:10.1038/cdd.2011.89 [doi] Read Publication

Fischer, M. M., Cancilla, B., Yeung, V. P., Cattaruzza, F., Chartier, C., Murriel, C. L., . . . Hoey, T. (2017). WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Science Advances, 3(6), e1700090. doi:10.1126/sciadv.1700090 [doi] Read Publication

Fischer, M. M., Yeung, V. P., Cattaruzza, F., Hussein, R., Yen, W. C., Murriel, C., . . . Hoey, T. (2017). RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common wnt pathway mutations. Scientific Reports, 7(1), 15270-017-15704-y. doi:10.1038/s41598-017-15704-y [doi] Read Publication

Friedrich, M., Henn, A., Raum, T., Bajtus, M., Matthes, K., Hendrich, L., . . . Rattel, B. (2014). Preclinical characterization of AMG 330, a CD3/CD33-bispecific T-cell-engaging antibody with potential for treatment of acute myelogenous leukemia. Molecular Cancer Therapeutics, 13(6), 1549-1557. doi:10.1158/1535-7163.MCT-13-0956 [doi] Read Publication

Galuppo, R., Maynard, E., Shah, M., Daily, M. F., Chen, C., Spear, B. T., & Gedaly, R. (2014). Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/beta-catenin pathways. Anticancer Research, 34(4), 1709-1713. doi:34/4/1709 [pii] Read Publication

Garg, G., Gibbs, J., Belt, B., Powell, M. A., Mutch, D. G., Goedegebuure, P., . . . Spitzer, D. (2014). Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein meso-TR3. BMC Cancer, 14, 35-2407-14-35. doi:10.1186/1471-2407-14-35 [doi] Read Publication

Gatt, S., & Dagan, A. (2012). Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Chemistry and Physics of Lipids, 165(4), 462-474. doi:10.1016/j.chemphyslip.2012.02.006 [doi] Read Publication

Gaudio, E., Tarantelli, C., Kwee, I., Barassi, C., Bernasconi, E., Rinaldi, A., . . . Bertoni, F. (2016). Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 27(6), 1123-1128. doi:10.1093/annonc/mdw131 [doi] Read Publication

Gaudio, E., Tarantelli, C., Ponzoni, M., Odore, E., Rezai, K., Bernasconi, E., . . . Bertoni, F. (2016). Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma. Oncotarget, 7(36), 58142-58147. doi:10.18632/oncotarget.10983 [doi] Read Publication

Gedaly, R., Galuppo, R., Daily, M. F., Shah, M., Maynard, E., Chen, C., . . . Spear, B. T. (2014). Targeting the Wnt/beta-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535. PloS One, 9(6), e99272. doi:10.1371/journal.pone.0099272 [doi] Read Publication

Giovannini, C., Baglioni, M., Baron Toaldo, M., Ventrucci, C., D'Adamo, S., Cipone, M., . . . Bolondi, L. (2013). Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. Oncotarget, 4(10), 1618-1631. doi:1221 [pii] Read Publication

Haas, T. L., Sciuto, M. R., Brunetto, L., Valvo, C., Signore, M., Fiori, M. E., . . . De Maria, R. (2017). Integrin alpha7 is a functional marker and potential therapeutic target in glioblastoma. Cell Stem Cell, 21(1), 35-50.e9. doi:S1934-5909(17)30137-6 [pii] Read Publication

Hassler, M. R., Klisaroska, A., Kollmann, K., Steiner, I., Bilban, M., Schiefer, A. I., . . . Egger, G. (2012). Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. Biochimie, 94(11), 2297-2307. doi:10.1016/j.biochi.2012.05.029 [doi] Read Publication

He, M., Tan, B., Vasan, K., Yuan, H., Cheng, F., Ramos da Silva, S., . . . Gao, S. J. (2017). SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells. The Journal of Pathology, 242(3), 309-321. doi:10.1002/path.4905 [doi] Read Publication

Hofmann, M., McCormack, E., Mujic, M., Rossberg, M., Bernd, A., Bereiter-Hahn, J., . . . Kippenberger, S. (2009). Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model. Neoplasia (New York, N.Y.), 11(8), 812-822. Read Publication

Kim, S., Jin, H., Seo, H. R., Lee, H. J., & Lee, Y. S. (2018). Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. Cell Death and Differentiation, doi:10.1038/s41418-018-0153-0 [doi] Read Publication

Kolev, V. N., Wright, Q. G., Vidal, C. M., Ring, J. E., Shapiro, I. M., Ricono, J., . . . Xu, Q. (2015). PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. Cancer Research, 75(2), 446-455. doi:10.1158/0008-5472.CAN-14-1223 [doi] Read Publication

Komar-Stossel, C., Gross, E., Dery, E., Corchia, N., Meir, K., Fried, I., & Abramovitch, R. (2014). TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI. PloS One, 9(3), e90224. doi:10.1371/journal.pone.0090224 [doi] Read Publication

Lamanuzzi, A., Saltarella, I., Desantis, V., Frassanito, M. A., Leone, P., Racanelli, V., . . . Ria, R. (2018). Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma. Oncotarget, 9(29), 20563-20577. doi:10.18632/oncotarget.25003 [doi] Read Publication

Laurent, S., Queirolo, P., Boero, S., Salvi, S., Piccioli, P., Boccardo, S., . . . Pistillo, M. P. (2013). The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production. Journal of Translational Medicine, 11, 108-5876-11-108. doi:10.1186/1479-5876-11-108 [doi] Read Publication

Leone, E., Morelli, E., Di Martino, M. T., Amodio, N., Foresta, U., Gulla, A., . . . Tassone, P. (2013). Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(8), 2096-2106. doi:10.1158/1078-0432.CCR-12-3325 [doi] Read Publication

Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W., & Huang, W. C. (2016). SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-myc in prostate cancer. Oncotarget, 7(11), 12869-12884. doi:10.18632/oncotarget.7331 [doi] Read Publication

Litzenburger, B. C., Creighton, C. J., Tsimelzon, A., Chan, B. T., Hilsenbeck, S. G., Wang, T., . . . Lee, A. V. (2011). High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(8), 2314-2327. doi:10.1158/1078-0432.CCR-10-1903 [doi] Read Publication

Liu, R., Shi, P., Nie, Z., Liang, H., Zhou, Z., Chen, W., . . . Chen, C. (2016). Mifepristone suppresses basal triple-negative breast cancer stem cells by down-regulating KLF5 expression. Theranostics, 6(4), 533-544. doi:10.7150/thno.14315 [doi] Read Publication

Londono-Joshi, A. I., Oliver, P. G., Li, Y., Lee, C. H., Forero-Torres, A., LoBuglio, A. F., & Buchsbaum, D. J. (2012). Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity. Breast Cancer Research and Treatment, 133(2), 437-445. doi:10.1007/s10549-011-1763-0 [doi] Read Publication

Lu, Y., Liu, Y., Oeck, S., & Glazer, P. M. (2018). Hypoxia promotes resistance to EGFR inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1. Molecular Cancer Research : MCR, 16(10), 1458-1469. doi:10.1158/1541-7786.MCR-17-0637 [doi] Read Publication

Lynam-Lennon, N., Heavey, S., Sommerville, G., Bibby, B. A., Ffrench, B., Quinn, J., . . . Maher, S. G. (2017). MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype. Oncotarget, 8(7), 11400-11413. doi:10.18632/oncotarget.13940 [doi] Read Publication

Melis, M. H., Simpson, K. L., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., . . . Illidge, T. M. (2013). Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death and Differentiation, 20(5), 765-773. doi:10.1038/cdd.2013.8 [doi] Read Publication

Moschetta, M., Basile, A., Ferrucci, A., Frassanito, M. A., Rao, L., Ria, R., . . . Vacca, A. (2013). Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(16), 4371-4382. doi:10.1158/1078-0432.CCR-13-0039 [doi] Read Publication

Ordonez, J. L., Amaral, A. T., Carcaboso, A. M., Herrero-Martin, D., del Carmen Garcia-Macias, M., Sevillano, V., . . . de Alava, E. (2015). The PARP inhibitor olaparib enhances the sensitivity of ewing sarcoma to trabectedin. Oncotarget, 6(22), 18875-18890. doi:10.18632/oncotarget.4303 [doi] Read Publication

Paolino, D., Cosco, D., Celano, M., Moretti, S., Puxeddu, E., Russo, D., & Fresta, M. (2013). Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. Nanomedicine (London, England), 8(2), 193-201. doi:10.2217/nnm.12.101 [doi] Read Publication

Paolino, D., Licciardi, M., Celia, C., Giammona, G., Fresta, M., & Cavallaro, G. (2012). Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 82(1), 94-102. doi:10.1016/j.ejpb.2012.06.001 [doi] Read Publication

Patyna, S., Laird, A. D., Mendel, D. B., O'farrell, A. M., Liang, C., Guan, H., . . . Hu-Lowe, D. (2006). SU14813: A novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity. Molecular Cancer Therapeutics, 5(7), 1774-1782. doi:5/7/1774 [pii] Read Publication

Pleniceanu, O., Shukrun, R., Omer, D., Vax, E., Kanter, I., Dziedzic, K., . . . Dekel, B. (2017). Peroxisome proliferator-activated receptor gamma (PPARgamma) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target. EMBO Molecular Medicine, 9(4), 508-530. doi:10.15252/emmm.201506111 [doi] Read Publication

Raimondi, L., Amodio, N., Di Martino, M. T., Altomare, E., Leotta, M., Caracciolo, D., . . . Tassone, P. (2014). Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity. Oncotarget, 5(10), 3039-3054. doi:1747 [pii] Read Publication

Rao, L., De Veirman, K., Giannico, D., Saltarella, I., Desantis, V., Frassanito, M. A., . . . Vacca, A. (2018). Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin((R)) protein MP0250: A preclinical study. Oncotarget, 9(17), 13366-13381. doi:10.18632/oncotarget.24351 [doi] Read Publication

Rodriguez-Barrueco, R., Yu, J., Saucedo-Cuevas, L. P., Olivan, M., Llobet-Navas, D., Putcha, P., . . . Silva, J. M. (2015). Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers. Genes & Development, 29(15), 1631-1648. doi:10.1101/gad.262642.115 [doi] Read Publication

Sabatino, M. A., Geroni, C., Ganzinelli, M., Ceruti, R., & Broggini, M. (2013). Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin. Epigenetics, 8(6), 656-665. doi:10.4161/epi.24916 [doi] Read Publication

Shin, D. Y., Kim, A., Kang, H. J., Park, S., Kim, D. W., & Lee, S. S. (2015). Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma. Cancer Letters, 364(2), 89-97. doi:10.1016/j.canlet.2015.03.016 [doi] Read Publication

Shir, A., Ogris, M., Roedl, W., Wagner, E., & Levitzki, A. (2011). EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(5), 1033-1043. doi:10.1158/1078-0432.CCR-10-1140 [doi] Read Publication

Signore, M., Buccarelli, M., Pilozzi, E., De Luca, G., Cappellari, M., Fanciulli, M., . . . Ricci-Vitiani, L. (2016). UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response. Oncotarget, 7(28), 44113-44128. doi:10.18632/oncotarget.9859 [doi] Read Publication

Smit, J. K., Faber, H., Niemantsverdriet, M., Baanstra, M., Bussink, J., Hollema, H., . . . Coppes, R. P. (2013). Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 107(3), 434-441. doi:10.1016/j.radonc.2013.03.027 [doi] Read Publication

Sommer, A., Kopitz, C., Schatz, C. A., Nising, C. F., Mahlert, C., Lerchen, H. G., . . . Kreft, B. (2016). Preclinical efficacy of the auristatin-based antibody-drug conjugate BAY 1187982 for the treatment of FGFR2-positive solid tumors. Cancer Research, 76(21), 6331-6339. doi:0008-5472.CAN-16-0180 [pii] Read Publication

Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., . . . Beierle, E. A. (2018). Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget, 9(32), 22665-22679. doi:10.18632/oncotarget.25205 [doi] Read Publication

Stewart, R., Morrow, M., Hammond, S. A., Mulgrew, K., Marcus, D., Poon, E., . . . McCourt, M. (2015). Identification and characterization of MEDI4736, an antagonistic anti-PD-L1 monoclonal antibody. Cancer Immunology Research, 3(9), 1052-1062. doi:10.1158/2326-6066.CIR-14-0191 [doi] Read Publication

Sun, L., Zhang, L., Qian, J., Yang, J., Yi, Q., Dong, W., & Wang, M. (2012). Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo. Leukemia Research, 36(3), 363-368. doi:10.1016/j.leukres.2011.09.014 [doi] Read Publication

Torres-Guzman, R., Calsina, B., Hermoso, A., Baquero, C., Alvarez, B., Amat, J., . . . Lallena, M. J. (2017). Preclinical characterization of abemaciclib in hormone receptor positive breast cancer. Oncotarget, 8(41), 69493-69507. doi:10.18632/oncotarget.17778 [doi] Read Publication

Van Impe, K., Bethuyne, J., Cool, S., Impens, F., Ruano-Gallego, D., De Wever, O., . . . Gettemans, J. (2013). A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis. Breast Cancer Research : BCR, 15(6), R116. doi:10.1186/bcr3585 [doi] Read Publication

Wang, L., Park, P., La Marca, F., Than, K., Rahman, S., & Lin, C. Y. (2013). Bone formation induced by BMP-2 in human osteosarcoma cells. International Journal of Oncology, 43(4), 1095-1102. doi:10.3892/ijo.2013.2030 [doi] Read Publication

Wang, L., Park, P., Zhang, H., La Marca, F., Claeson, A., Than, K., . . . Lin, C. Y. (2012). BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. International Journal of Cancer.Journal International Du Cancer, 131(8), 1941-1950. doi:10.1002/ijc.27444 [doi] Read Publication

Was, H., Barszcz, K., Czarnecka, J., Kowalczyk, A., Bernas, T., Uzarowska, E., . . . Sikora, E. (2017). Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice. Oncotarget, 8(6), 9303-9322. doi:10.18632/oncotarget.14066 [doi] Read Publication

Wennier, S. T., Liu, J., Li, S., Rahman, M. M., Mona, M., & McFadden, G. (2012). Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer. Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(4), 759-768. doi:10.1038/mt.2011.293 [doi] Read Publication

Yen, W. C., Fischer, M. M., Hynes, M., Wu, J., Kim, E., Beviglia, L., . . . Hoey, T. (2012). Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-notch signaling in both tumor and vasculature cells. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(19), 5374-5386. doi:10.1158/1078-0432.CCR-12-0736 [doi] Read Publication

Zaoui, K., Bossow, S., Grossardt, C., Leber, M. F., Springfeld, C., Plinkert, P. K., . . . Ungerechts, G. (2012). Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus. Cancer Gene Therapy, 19(3), 181-191. doi:10.1038/cgt.2011.75 [doi] Read Publication

Zarrinkar, P. P., Gunawardane, R. N., Cramer, M. D., Gardner, M. F., Brigham, D., Belli, B., . . . Bhagwat, S. S. (2009). AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood, 114(14), 2984-2992. doi:10.1182/blood-2009-05-222034 [doi] Read Publication

Zhu, C., Cheng, K. W., Ouyang, N., Huang, L., Sun, Y., Constantinides, P., & Rigas, B. (2012). Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Stem Cells (Dayton, Ohio), 30(10), 2065-2075. doi:10.1002/stem.1139 [doi] Read Publication

Achyut, B. R., Shankar, A., Iskander, A. S., Ara, R., Knight, R. A., Scicli, A. G., & Arbab, A. S. (2016). Chimeric mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments. Cancer Biology & Therapy, 17(3), 280-290. doi:10.1080/15384047.2016.1139243 [doi] Read Publication

Andretta, E., Carton-Garcia, F., Martinez-Barriocanal, A., de Marcondes, P. G., Jimenez-Flores, L. M., Macaya, I., . . . Arango, D. (2017). Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. Scientific Reports, 7, 41576. doi:10.1038/srep41576 [doi] Read Publication

Bellavia, D., Raimondo, S., Calabrese, G., Forte, S., Cristaldi, M., Patinella, A., . . . Alessandro, R. (2017). Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth. Theranostics, 7(5), 1333-1345. doi:10.7150/thno.17092 [doi] Read Publication

Boesch, M., Zeimet, A. G., Reimer, D., Schmidt, S., Gastl, G., Parson, W., . . . Sopper, S. (2014). The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget, 5(16), 7027-7039. doi:2053 [pii] Read Publication

Carrascosa, C., Obula, R. G., Missiaglia, E., Lehr, H. A., Delorenzi, M., Frattini, M., . . . Mariotti, A. (2012). MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Oncogene, 31(12), 1521-1532. doi:10.1038/onc.2011.356 [doi] Read Publication

Dattilo, V., D'Antona, L., Talarico, C., Capula, M., Catalogna, G., Iuliano, R., . . . Amato, R. (2017). SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: A new route of epigenomic regulation. Scientific Reports, 7, 45361. doi:10.1038/srep45361 [doi] Read Publication

Desiderio, V., Papagerakis, P., Tirino, V., Zheng, L., Matossian, M., Prince, M. E., . . . Papagerakis, S. (2015). Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells. Oncotarget, 6(1), 71-84. doi:2698 [pii] Read Publication

Desiderio, V., Papagerakis, P., Tirino, V., Zheng, L., Matossian, M., Prince, M. E., . . . Papagerakis, S. (2015). Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells. Oncotarget, 6(1), 71-84. doi:2698 [pii] Read Publication

Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, A. P., . . . Salomoni, P. (2016). A promyelocytic leukemia protein-thrombospondin-2 axis and the risk of relapse in neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(13), 3398-3409. doi:10.1158/1078-0432.CCR-15-2081 [doi] Read Publication

Escobar-Hoyos, L. F., Shah, R., Roa-Pena, L., Vanner, E. A., Najafian, N., Banach, A., . . . Shroyer, K. R. (2015). Keratin-17 promotes p27KIP1 nuclear export and degradation and offers potential prognostic utility. Cancer Research, 75(17), 3650-3662. doi:10.1158/0008-5472.CAN-15-0293 [doi] Read Publication

Escobar-Hoyos, L. F., Shah, R., Roa-Pena, L., Vanner, E. A., Najafian, N., Banach, A., . . . Shroyer, K. R. (2015). Keratin-17 promotes p27KIP1 nuclear export and degradation and offers potential prognostic utility. Cancer Research, 75(17), 3650-3662. doi:10.1158/0008-5472.CAN-15-0293 [doi] Read Publication

Fareh, M., Almairac, F., Turchi, L., Burel-Vandenbos, F., Paquis, P., Fontaine, D., . . . Virolle, T. (2017). Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth. Cell Death & Disease, 8(3), e2713. doi:10.1038/cddis.2017.117 [doi] Read Publication

Fareh, M., Turchi, L., Virolle, V., Debruyne, D., Almairac, F., de-la-Forest Divonne, S., . . . Virolle, T. (2012). The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death and Differentiation, 19(2), 232-244. doi:10.1038/cdd.2011.89 [doi] Read Publication

Frassanito, M. A., Rao, L., Moschetta, M., Ria, R., Di Marzo, L., De Luisi, A., . . . Vacca, A. (2014). Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies. Leukemia, 28(4), 904-916. doi:10.1038/leu.2013.254 [doi] Read Publication

Frosina, G., Ravetti, J. L., Corvo, R., Fella, M., Garre, M. L., Levrero, F., . . . Daga, A. (2018). Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1. Scientific Reports, 8(1), 14191-018-32578-w. doi:10.1038/s41598-018-32578-w [doi] Read Publication

Houben, R., Adam, C., Baeurle, A., Hesbacher, S., Grimm, J., Angermeyer, S., . . . Schrama, D. (2012). An intact retinoblastoma protein-binding site in merkel cell polyomavirus large T antigen is required for promoting growth of merkel cell carcinoma cells. International Journal of Cancer.Journal International Du Cancer, 130(4), 847-856. doi:10.1002/ijc.26076 [doi] Read Publication

Howley, B. V., Link, L. A., Grelet, S., El-Sabban, M., & Howe, P. H. (2018). A CREB3-regulated ER-golgi trafficking signature promotes metastatic progression in breast cancer. Oncogene, 37(10), 1308-1325. doi:10.1038/s41388-017-0023-0 [doi] Read Publication

James, M. I., Howells, L. M., Karmokar, A., Higgins, J. A., Greaves, P., Cai, H., . . . Brown, K. (2015). Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: Trials, tribulations and a cautionary note. PloS One, 10(2), e0117776. doi:10.1371/journal.pone.0117776 [doi] Read Publication

James, M. I., Howells, L. M., Karmokar, A., Higgins, J. A., Greaves, P., Cai, H., . . . Brown, K. (2015). Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: Trials, tribulations and a cautionary note. PloS One, 10(2), e0117776. doi:10.1371/journal.pone.0117776 [doi] Read Publication

Kar, A., & Gutierrez-Hartmann, A. (2017). ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2(+) breast cancer patients and is critical for tumorigenesis in HER2(+) breast cancer cells. Oncotarget, 8(41), 69622-69640. doi:10.18632/oncotarget.18710 [doi] Read Publication

Krelin, Y., Berkovich, L., Amit, M., & Gil, Z. (2013). Association between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model. PloS One, 8(4), e62124. doi:10.1371/journal.pone.0062124 [doi] Read Publication

Levy, L., Mishalian, I., Bayuch, R., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2015). Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response. Oncoimmunology, 4(4), e998469. doi:10.1080/2162402X.2014.998469 [doi] Read Publication

Louie, E., Chen, X. F., Coomes, A., Ji, K., Tsirka, S., & Chen, E. I. (2013). Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene, 32(35), 4064-4077. doi:10.1038/onc.2012.417 [doi] Read Publication

Lourenco, S., Teixeira, V. H., Kalber, T., Jose, R. J., Floto, R. A., & Janes, S. M. (2015). Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors. Journal of Immunology (Baltimore, Md.: 1950), 194(7), 3463-3474. doi:10.4049/jimmunol.1402097 [doi] Read Publication

Marlow, R., Honeth, G., Lombardi, S., Cariati, M., Hessey, S., Pipili, A., . . . Dontu, G. (2013). A novel model of dormancy for bone metastatic breast cancer cells. Cancer Research, 73(23), 6886-6899. doi:10.1158/0008-5472.CAN-13-0991 [doi] Read Publication

Mathieu, M. G., Miles, A. K., Ahmad, M., Buczek, M. E., Pockley, A. G., Rees, R. C., & Regad, T. (2014). The helicase HAGE prevents interferon-alpha-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease, 5, e1061. doi:10.1038/cddis.2014.29 [doi] Read Publication

Mei, J., Bachoo, R., & Zhang, C. L. (2011). MicroRNA-146a inhibits glioma development by targeting Notch1. Molecular and Cellular Biology, 31(17), 3584-3592. doi:10.1128/MCB.05821-11 [doi] Read Publication

Onion, D., Argent, R. H., Reece-Smith, A. M., Craze, M. L., Pineda, R. G., Clarke, P. A., . . . Grabowska, A. M. (2016). 3-dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors. Molecular Cancer Therapeutics, 15(4), 753-763. doi:10.1158/1535-7163.MCT-15-0598 [doi] Read Publication

Qureshi-Baig, K., Ullmann, P., Rodriguez, F., Frasquilho, S., Nazarov, P. V., Haan, S., & Letellier, E. (2016). What do we learn from spheroid culture systems? insights from tumorspheres derived from primary colon cancer tissue. PloS One, 11(1), e0146052. doi:10.1371/journal.pone.0146052 [doi] Read Publication

Sage, E. K., Kolluri, K. K., McNulty, K., Lourenco Sda, S., Kalber, T. L., Ordidge, K. L., . . . Janes, S. M. (2014). Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma. Thorax, 69(7), 638-647. doi:10.1136/thoraxjnl-2013-204110 [doi] Read Publication

Salvatori, L., Caporuscio, F., Verdina, A., Starace, G., Crispi, S., Nicotra, M. R., . . . Petrangeli, E. (2012). Cell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors. PloS One, 7(2), e31467. doi:10.1371/journal.pone.0031467 [doi] Read Publication

Shetzer, Y., Kagan, S., Koifman, G., Sarig, R., Kogan-Sakin, I., Charni, M., . . . Aloni-Grinstein, R. (2014). The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele. Cell Death and Differentiation, 21(9), 1419-1431. doi:10.1038/cdd.2014.57 [doi] Read Publication

Shoshani, O., Massalha, H., Shani, N., Kagan, S., Ravid, O., Madar, S., . . . Zipori, D. (2012). Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity. Cancer Research, 72(24), 6403-6413. doi:10.1158/0008-5472.CAN-12-1155 [doi] Read Publication

Song, W., Hwang, Y., Youngblood, V. M., Cook, R. S., Balko, J. M., Chen, J., & Brantley-Sieders, D. M. (2017). Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers. Oncogene, 36(40), 5620-5630. doi:10.1038/onc.2017.170 [doi] Read Publication

Stamatakis, K., Jimenez-Martinez, M., Jimenez-Segovia, A., Chico-Calero, I., Conde, E., Galan-Martinez, J., . . . Fresno, M. (2015). Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression. Oncotarget, 6(37), 39941-39959. doi:10.18632/oncotarget.5402 [doi] Read Publication

Stivarou, T., Stellas, D., Vartzi, G., Thomaidou, D., & Patsavoudi, E. (2016). Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo. Cancer Biology & Therapy, 17(8), 799-812. doi:10.1080/15384047.2016.1195041 [doi] Read Publication

Sukowati, C. H., Anfuso, B., Croce, L. S., & Tiribelli, C. (2015). The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis. BMC Cancer, 15, 188-015-1196-y. doi:10.1186/s12885-015-1196-y [doi] Read Publication

Sukowati, C. H., Anfuso, B., Torre, G., Francalanci, P., Croce, L. S., & Tiribelli, C. (2013). The expression of CD90/Thy-1 in hepatocellular carcinoma: An in vivo and in vitro study. PloS One, 8(10), e76830. doi:10.1371/journal.pone.0076830 [doi] Read Publication

Talarico, C., D'Antona, L., Scumaci, D., Barone, A., Gigliotti, F., Fiumara, C. V., . . . Amato, R. (2015). Preclinical model in HCC: The SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy. Oncotarget, 6(35), 37511-37525. doi:10.18632/oncotarget.5527 [doi] Read Publication

Tancioni, I., Miller, N. L., Uryu, S., Lawson, C., Jean, C., Chen, X. L., . . . Schlaepfer, D. D. (2015). FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Breast Cancer Research : BCR, 17, 47-015-0551-x. doi:10.1186/s13058-015-0551-x [doi] Read Publication

Tancioni, I., Miller, N. L., Uryu, S., Lawson, C., Jean, C., Chen, X. L., . . . Schlaepfer, D. D. (2015). FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Breast Cancer Research : BCR, 17, 47-015-0551-x. doi:10.1186/s13058-015-0551-x [doi] Read Publication

Turchi, L., Debruyne, D. N., Almairac, F., Virolle, V., Fareh, M., Neirijnck, Y., . . . Virolle, T. (2013). Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling. Stem Cells (Dayton, Ohio), 31(7), 1252-1265. doi:10.1002/stem.1373 [doi] Read Publication

Wang, L., Park, P., La Marca, F., Than, K. D., & Lin, C. Y. (2015). BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation. Journal of Cancer Research and Clinical Oncology, 141(6), 1013-1024. doi:10.1007/s00432-014-1883-0 [doi] Read Publication

Wardwell-Ozgo, J., Dogruluk, T., Gifford, A., Zhang, Y., Heffernan, T. P., van Doorn, R., . . . Scott, K. L. (2014). HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene, 33(8), 1017-1026. doi:10.1038/onc.2013.30 [doi] Read Publication

Zhi, X., Zhao, D., Wang, Z., Zhou, Z., Wang, C., Chen, W., . . . Chen, C. (2013). E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation. Cancer Research, 73(1), 385-394. doi:10.1158/0008-5472.CAN-12-0562 [doi] Read Publication

Zhu, L., Cheng, X., Shi, J., Jiacheng, L., Chen, G., Jin, H., . . . Tu, S. P. (2016). Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis. Oncogene, 35(41), 5388-5399. doi:10.1038/onc.2016.76 [doi] Read Publication

Zorniak, M., Clark, P. A., & Kuo, J. S. (2015). Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells. Journal of Neurosurgery, 122(1), 69-77. doi:10.3171/2014.9.JNS132373 [doi] Read Publication

Argyros, O., Wong, S. P., Gowers, K., & Harbottle, R. P. (2012). Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling. PloS One, 7(10), e47920. doi:10.1371/journal.pone.0047920 [doi] Read Publication

Banerjee, K., Pru, C., Pru, J. K., & Resat, H. (2018). STAT3 knockdown induces tumor formation by MDA-MB-231 cells. Clinical Oncology and Research, 1(1) doi:10.31487/j.COR.2018.10.002 [doi] Read Publication

Buzhor, E., Omer, D., Harari-Steinberg, O., Dotan, Z., Vax, E., Pri-Chen, S., . . . Dekel, B. (2013). Reactivation of NCAM1 defines a subpopulation of human adult kidney epithelial cells with clonogenic and stem/progenitor properties. The American Journal of Pathology, 183(5), 1621-1633. doi:10.1016/j.ajpath.2013.07.034 [doi] Read Publication

Calles, A., Rubio-Viqueira, B., & Hidalgo, M. (2013). Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology. Current Protocols in Pharmacology / Editorial Board, S.J.Enna (Editor-in-Chief) ...[Et Al.], Chapter 14, Unit 14.26. doi:10.1002/0471141755.ph1426s61 [doi] Read Publication

Chartier, C., Raval, J., Axelrod, F., Bond, C., Cain, J., Dee-Hoskins, C., . . . Gurney, A. (2016). Therapeutic targeting of tumor-derived R-spondin attenuates beta-catenin signaling and tumorigenesis in multiple cancer types. Cancer Research, 76(3), 713-723. doi:10.1158/0008-5472.CAN-15-0561 [doi] Read Publication

Feys, L., Descamps, B., Vanhove, C., Vermeulen, S., Vandesompele, J. O., Vanderheyden, K., . . . De Wever, O. (2016). Quantitative and functional requirements for bioluminescent cancer models. In Vivo (Athens, Greece), 30(1), 1-11. doi:30/1/1 [pii] Read Publication

Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y. P., Van den Eynde, K., Van den Broeck, A., . . . Roskams, T. (2016). Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. Journal of Hepatology, 64(3), 609-617. doi:10.1016/j.jhep.2015.11.011 [doi] Read Publication

Hargus, G., Ehrlich, M., Arauzo-Bravo, M. J., Hemmer, K., Hallmann, A. L., Reinhardt, P., . . . Zaehres, H. (2014). Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain. Cell Reports, 8(6), 1697-1703. doi:10.1016/j.celrep.2014.08.014 [doi] Read Publication

Lima, M. J., Muir, K. R., Docherty, H. M., Drummond, R., McGowan, N. W., Forbes, S., . . . Docherty, K. (2013). Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing beta-like cells. Diabetes, 62(8), 2821-2833. doi:10.2337/db12-1256 [doi] Read Publication

Loebinger, M. R., Kyrtatos, P. G., Turmaine, M., Price, A. N., Pankhurst, Q., Lythgoe, M. F., & Janes, S. M. (2009). Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Research, 69(23), 8862-8867. doi:10.1158/0008-5472.CAN-09-1912 [doi] Read Publication

Maldonado, A. A., Cristobal, L., Martin-Lopez, J., Mallen, M., Garcia-Honduvilla, N., & Bujan, J. (2014). A novel model of human skin pressure ulcers in mice. PloS One, 9(10), e109003. doi:10.1371/journal.pone.0109003 [doi] Read Publication

Marin-Ramos, N. I., Thein, T. Z., Cho, H. Y., Swenson, S. D., Wang, W., Schonthal, A. H., . . . Hofman, F. M. (2018). NEO212 inhibits migration and invasion of glioma stem cells. Molecular Cancer Therapeutics, 17(3), 625-637. doi:10.1158/1535-7163.MCT-17-0591 [doi] Read Publication

Milazzo, L., Vulcano, F., Barca, A., Macioce, G., Paldino, E., Rossi, S., . . . Giampaolo, A. (2014). Cord blood CD34+ cells expanded on wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice. European Journal of Haematology, 93(5), 384-391. doi:10.1111/ejh.12363 [doi] Read Publication

Owonikoko, T. K., Zhang, G., Kim, H. S., Stinson, R. M., Bechara, R., Zhang, C., . . . Khuri, F. R. (2016). Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of Translational Medicine, 14(1), 111-016-0861-5. doi:10.1186/s12967-016-0861-5 [doi] Read Publication

Peled, T., Shoham, H., Aschengrau, D., Yackoubov, D., Frei, G., Rosenheimer, G. N., . . . Peled, A. (2012). Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Experimental Hematology, 40(4), 342-55.e1. doi:10.1016/j.exphem.2011.12.005 [doi] Read Publication

Petrillo, L. A., Wolf, D. M., Kapoun, A. M., Wang, N. J., Barczak, A., Xiao, Y., . . . Esserman, L. J. (2012). Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors. Breast Cancer Research and Treatment, 135(3), 913-922. doi:10.1007/s10549-012-2226-y [doi] Read Publication

Rauner, G., & Barash, I. (2014). Xanthosine administration does not affect the proportion of epithelial stem cells in bovine mammary tissue, but has a latent negative effect on cell proliferation. Experimental Cell Research, 328(1), 186-196. doi:10.1016/j.yexcr.2014.06.017 [doi] Read Publication

Thomson, A. J., Pierart, H., Meek, S., Bogerman, A., Sutherland, L., Murray, H., . . . Burdon, T. (2012). Reprogramming pig fetal fibroblasts reveals a functional LIF signaling pathway. Cellular Reprogramming, 14(2), 112-122. doi:10.1089/cell.2011.0078 [doi] Read Publication

Vulcano, F., Milazzo, L., Ciccarelli, C., Barca, A., Agostini, F., Altieri, I., . . . Hassan, H. J. (2012). Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice. Experimental Cell Research, 318(4), 400-407. doi:10.1016/j.yexcr.2011.11.012 [doi] Read Publication

Wang, L., Rahman, S., Lin, C. Y., Valdivia, J., Than, K., La Marca, F., & Park, P. (2012). A novel murine model of human renal cell carcinoma spinal metastasis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 19(6), 881-883. doi:10.1016/j.jocn.2011.10.019 [doi] Read Publication

Westenfelder, C., Gooch, A., Hu, Z., Ahlstrom, J., & Zhang, P. (2017). Durable control of autoimmune diabetes in mice achieved by intraperitoneal transplantation of "neo-islets," three-dimensional aggregates of allogeneic islet and "mesenchymal stem cells". Stem Cells Translational Medicine, 6(7), 1631-1643. doi:10.1002/sctm.17-0005 [doi] Read Publication

Yuan, X., Wei, Y., Villasante, A., Ng, J. J. D., Arkonac, D. E., Chao, P. G., & Vunjak-Novakovic, G. (2017). Stem cell delivery in tissue-specific hydrogel enabled meniscal repair in an orthotopic rat model. Biomaterials, 132, 59-71. doi:S0142-9612(17)30213-2 [pii] Read Publication

Zhang, Y., Zheng, D., Zhou, T., Song, H., Hulsurkar, M., Su, N., . . . Li, W. (2018). Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nature Communications, 9(1), 4080-018-06177-2. doi:10.1038/s41467-018-06177-2 [doi] Read Publication

Gunasekaran, K., Pentony, M., Shen, M., Garrett, L., Forte, C., Woodward, A., . . . Yan, W. (2010). Enhancing antibody fc heterodimer formation through electrostatic steering effects: Applications to bispecific molecules and monovalent IgG. The Journal of Biological Chemistry, 285(25), 19637-19646. doi:10.1074/jbc.M110.117382 [doi] Read Publication

Lin, G. H. Y., Chai, V., Lee, V., Dodge, K., Truong, T., Wong, M., . . . Viller, N. N. (2017). TTI-621 (SIRPalphaFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets. PloS One, 12(10), e0187262. doi:10.1371/journal.pone.0187262 [doi] Read Publication

Melis, M. H., Simpson, K. L., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., . . . Illidge, T. M. (2013). Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death and Differentiation, 20(5), 765-773. doi:10.1038/cdd.2013.8 [doi] Read Publication

Oberst, M. D., Auge, C., Morris, C., Kentner, S., Mulgrew, K., McGlinchey, K., . . . Hammond, S. A. (2018). Potent immune modulation by MEDI6383, an engineered human OX40 ligand IgG4P fc fusion protein. Molecular Cancer Therapeutics, 17(5), 1024-1038. doi:10.1158/1535-7163.MCT-17-0200 [doi] Read Publication

Precechtelova, J., Borsanyiova, M., Stipalova, D., Sarmirova, S., Gomolcak, P., Berakova, K., & Bopegamage, S. (2015). Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2. Archives of Virology, 160(1), 103-115. doi:10.1007/s00705-014-2236-7 [doi] Read Publication

Reuter, J. D., Fang, X., Ly, C. S., Suter, K. K., & Gibbs, D. (2012). Assessment of hazard risk associated with the intravenous use of viral vectors in rodents. Comparative Medicine, 62(5), 361-370. Read Publication

Wooddell, C. I., Rozema, D. B., Hossbach, M., John, M., Hamilton, H. L., Chu, Q., . . . Lewis, D. L. (2013). Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Molecular Therapy : The Journal of the American Society of Gene Therapy, 21(5), 973-985. doi:10.1038/mt.2013.31 [doi] Read Publication